Downregulation of miR-23a and miR-24 in human hepatocellular carcinoma cells by Sorafenib via transforming growth factor-beta 1 in a SMAD dependent manner - Egyptian Knowledge Bank - troweb

147398

Downregulation of miR-23a and miR-24 in human hepatocellular carcinoma cells by Sorafenib via transforming growth factor-beta 1 in a SMAD dependent manner

Article

Last updated: 04 Jan 2025

Overview Similar Items

Article

Molecular Insights into The Biological Basis of Anticancer Efficacy of miRNA Suppression Therapy in HCC Cell Lines

Article

Serum MiRNA-23a as a Diagnostic and Prognostic Biomarker of Hepatitis C Related Hepatocellular Carcinoma

Article

Expression of MicroRNA-24 in Aflatoxin B1 Exposed Patients with Hepatocellular Carcinoma and Cirrhosis

Article

Serum mir-30e and mir-223 as novel noninvasive biomarkers for hepatocellular carcinoma

Article

Alterations of Some MicroRNAs Expression in Hepatocellular Carcinoma Cell Lines by Sodium Butyrate

Article

MicroRNA-15a expression level and its target “c-Myb” expression in Hepatocellular carcinoma Among Chronic HCV Egyptian Patients

Article

CYTOTOXICITY OF SORAFENIB IN HUMAN HEPATOCELLULAR CARCINOMA CELLS

Article

Significance of MicroRNA-200a and Long Noncoding RNA-HULC Expression in HCV-Associated Hepatocellular Carcinoma

Article

MicroRNA 122 as adiagnostic biomarker for hepatitis C- related hepatocellular carcinoma

Article

miR-203 and endocan as diagnostic markers for hepatocellular carcinoma related viral infections